Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shire Waives OFT Approval Condition In ViroPharma Acquisition

15th Jan 2014 14:51

LONDON (Alliance News) - Shire PLC said Wednesday that it expects to complete its acquisition of ViroPharma Inc. January 24, after it waived the Office of Fair Trading's approval condition to its tender offer for all outstanding shares in Viropharma.

Shire extended its tender offer for ViroPharma for a second time last Friday. It was originally scheduled to expire last Thursday. As at last Friday, Shire had received valid acceptances representing 78% of ViroPharma's stock.

Shares in Shire were trading up 0.4%, or 12.37 pence, at 3,003.37 pence Wednesday afternoon.

By Hana Stewart-Smith; [email protected]; @hanassallnews

Copyright © 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

Shire
FTSE 100 Latest
Value8,887.80
Change78.06